A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta

This publication has 34 references indexed in Scilit:

• Brittle bones - fragile molecules: disorders of collagen gene structure and expression
  Published by Elsevier ,2002
• Bone disease cracks genetics
  Nature, 1990
• The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.
  Journal of Medical Genetics, 1990
• Fibrillar Collagen Genes.
  Annals of the New York Academy of Sciences, 1990
• Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.
  Journal of Clinical Investigation, 1989
• Type I procollagen: The gene‐protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue
  American Journal of Medical Genetics, 1989
• A new lethal brittle bone syndrome with increased amount of type V collagen in a patient
  American Journal of Medical Genetics, 1989
• Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-α1(I) collagen gene
  Nature, 1988
• Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III)
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
• Nucleotide sequences of complementary deoxyribonucleic acids for the pro.alpha.1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolution
  Biochemistry, 1983